172 related articles for article (PubMed ID: 16122475)
21. Examination of p53 alterations and cytokeratin expression in sputa collected from patients prior to histological diagnosis of squamous cell carcinoma.
Anderson M; Sladon S; Michels R; Davidson L; Conwell K; Lechner J; Franklin W; Saccomanno G; Wiest J
J Cell Biochem Suppl; 1996; 25():185-90. PubMed ID: 9027617
[TBL] [Abstract][Full Text] [Related]
22. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies.
Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S
Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241
[TBL] [Abstract][Full Text] [Related]
23. Mutant p53 product in patients with stage III cervical cancer.
Gitsch G; Kainz C; Joura E; Breitenecker G
Anticancer Res; 1992; 12(6B):2241-2. PubMed ID: 1295470
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric DNA analysis of submucosal carcinoma of the esophagus.
Hui AM; Itabashi M; Kato H; Tachimori Y; Watanabe H; Hirota T
Jpn J Clin Oncol; 1994 Feb; 24(1):26-31. PubMed ID: 8126917
[TBL] [Abstract][Full Text] [Related]
25. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.
Mori T; Miura K; Aoki T; Nishihira T; Mori S; Nakamura Y
Cancer Res; 1994 Jul; 54(13):3396-7. PubMed ID: 8012957
[TBL] [Abstract][Full Text] [Related]
26. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.
Kitagawa Y; Ueda M; Ando N; Shinozawa Y; Shimizu N; Abe O
Cancer Res; 1991 Mar; 51(5):1504-8. PubMed ID: 1997190
[TBL] [Abstract][Full Text] [Related]
27. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma.
Tanigawa N; Matsumura M; Amaya H; Kitaoka A; Shimomatsuya T; Lu C; Muraoka R; Tanaka T
Cancer; 1997 Jan; 79(2):220-5. PubMed ID: 9010094
[TBL] [Abstract][Full Text] [Related]
28. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.
Bennett WP; Hollstein MC; He A; Zhu SM; Resau JH; Trump BF; Metcalf RA; Welsh JA; Midgley C; Lane DP
Oncogene; 1991 Oct; 6(10):1779-84. PubMed ID: 1923503
[TBL] [Abstract][Full Text] [Related]
29. [Overexpression of p53 in transitional cell carcinoma of the ovary].
Shen K; Lang J; Guo L
Zhonghua Fu Chan Ke Za Zhi; 1995 Mar; 30(3):153-6. PubMed ID: 7796648
[TBL] [Abstract][Full Text] [Related]
30. Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinoma.
Tempfer C; Gitsch G; Hanzal E; Reinthaller A; Koelbl H; Kainz C
Anticancer Res; 1996; 16(4A):2029-31. PubMed ID: 8712738
[TBL] [Abstract][Full Text] [Related]
31. Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus.
Hippeläinen M; Eskelinen M; Lipponen P; Chang F; Syrjänen K
Anticancer Res; 1993; 13(3):677-81. PubMed ID: 8391246
[TBL] [Abstract][Full Text] [Related]
32. Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors.
von Brevern MC; Hollstein MC; Cawley HM; De Benedetti VM; Bennett WP; Liang L; He AG; Zhu SM; Tursz T; Janin N; Trivers GE
Cancer Res; 1996 Nov; 56(21):4917-21. PubMed ID: 8895744
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of the p16INK4, p15INK4B genes abnormality and the amplification of cyclin D1 gene in esophageal cancer].
Takamura H; Fushida S; Hashimoto T; Yagi M; Miyazaki I
Nihon Rinsho; 1996 Apr; 54(4):1043-8. PubMed ID: 8920671
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.
Fujino M; Dosaka-Akita H; Harada M; Hiroumi H; Kinoshita I; Akie K; Kawakami Y
Cancer; 1995 Dec; 76(12):2457-63. PubMed ID: 8625071
[TBL] [Abstract][Full Text] [Related]
35. [Genetic events during development of esophageal squamous cell carcinoma].
Sasaki H; Watanabe H; Terada M
Nihon Rinsho; 1996 Apr; 54(4):1060-5. PubMed ID: 8920674
[TBL] [Abstract][Full Text] [Related]
36. In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma.
Sasano H; Goukon Y; Nishihira T; Nagura H
Am J Pathol; 1992 Sep; 141(3):545-50. PubMed ID: 1519662
[TBL] [Abstract][Full Text] [Related]
37. Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis.
Kropveld A; Slootweg PJ; van Mansfeld AD; Blankenstein MA; Hordijk GJ
Cancer; 1996 Sep; 78(5):991-7. PubMed ID: 8780536
[TBL] [Abstract][Full Text] [Related]
38. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus.
Sarbia M; Porschen R; Borchard F; Horstmann O; Willers R; Gabbert HE
Cancer; 1994 Oct; 74(8):2218-23. PubMed ID: 7922972
[TBL] [Abstract][Full Text] [Related]
39. [Alterations of oncogenes in human fetal esophageal epithelium induced by N-methylbenzylnitrosamine (NMBzA)].
Guo YJ; Lu SX; Liang YY
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):407-10. PubMed ID: 7720492
[TBL] [Abstract][Full Text] [Related]
40. TP53 gene mutation profile in esophageal squamous cell carcinomas.
Audrézet MP; Robaszkiewicz M; Mercier B; Nousbaum JB; Bail JP; Hardy E; Volant A; Lozac'h P; Charles JF; Gouéron H
Cancer Res; 1993 Dec; 53(23):5745-9. PubMed ID: 8242631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
